In Part 3 of this expert-led series on alopecia areata (AA), Drs Brittany Craiglow, Brett King, and Maryanne Senna shift the focus to the emotional, psychosocial, and holistic care needs ...
In Part 2 of our expert-led discussion on alopecia areata (AA), dermatologists Dr Brittany Craiglow, Dr Brett King, and Dr Maryanne Senna dive into one of the most important breakthroughs...
In this expert roundtable, Drs Brittany Craiglow, Brett King, and Maryanne Senna discuss the emotional and psychosocial weight patients carry—and how clinicians can meet their needs with ...
In this interview, Dr Travis Blalock shares valuable insights on dermatologic surgery for non-Mohs surgeons. From identifying key surgical pearls to managing challenges like bleeding and tension, Blalock shares invaluable strategies and...
In this interview, Dr Travis Blalock shares valuable insights on dermatologic surgery for non-Mohs surgeons. From identifying key surgical pearls to managing challenges like bleeding and tension, Blalock shares invaluable strategies and...
The US Food and Drug Administration (FDA) has recently approved an expansion for the use of Klisyri (tirbanibulin) to treat actinic keratosis (AK) on larger areas of the face or scalp, up to 100 cm².
The US Food and Drug Administration (FDA) has recently approved an expansion for the use of Klisyri (tirbanibulin) to treat actinic keratosis (AK) on larger areas of the face or scalp, up to 100 cm².
Researchers utilized data from the British Association of Dermatologists Biologics and Immunomodulators Register, focusing on adults treated with biologics for plaque psoriasis.
Researchers utilized data from the British Association of Dermatologists Biologics and Immunomodulators Register, focusing on adults treated with biologics for plaque psoriasis.
A healthy 42-year-old woman with fair skin (Fitzpatrick type 2) and no significant past medical history presented to the clinic with concerns about a dry, rough lesion on her left ear.
A healthy 42-year-old woman with fair skin (Fitzpatrick type 2) and no significant past medical history presented to the clinic with concerns about a dry, rough lesion on her left ear.
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Assess the nuanced emotional and functional burden of eyebrow and eyelash loss in AA patients and how it differs from scalp hair loss in clinical practice.
Assess the nuanced emotional and functional burden of eyebrow and eyelash loss in AA patients and how it differs from scalp hair loss in clinical practice.